Madrigal (MDGL) Reports Q4 Loss, Beats Revenue Estimates

Madrigal (MDGL) came out with a quarterly loss of $2.57 per share versus the Zacks Consensus Estimate of $0.04. This compares to a loss of $2.71 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -7,442.86%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $1.98 per share when it actually produced a loss of $5.08, delivering a surprise of -156.57%.Over the last four quarters, the company has ...